老年患者放射性头部骨折的利用和医生补偿模式
Evan H Richman1, Dylan R Rakowski1, Jack C Hop1
1Department of Orthopedic Surgery, University of Colorado Anschutz Medical Campus, Aurora, USA.
概括
医疗保险受益人的辐射头骨折的治疗显示了向辐射头关节整形术 (RHA) 而不是开放缩减内部固定 (ORIF) 的转变. 这些骨折治疗的医生补偿总体上有所增加.
科学领域:
- 整形外科手术 整形外科手术
- 医疗服务研究 医疗服务研究
- 医疗保险索赔分析
背景情况:
- 辐射头部骨折是常见的伤害,最优的管理有争议,特别是在老年患者.
- 了解长期治疗趋势和财务影响对于医疗保健提供者和政策制定者来说至关重要.
研究的目的:
- 分析医疗保险人口中放射性头部骨折管理的20年趋势.
- 检查放射性头部骨折不同治疗方式的医生补偿模式.
主要方法:
- 使用的医疗保险B部分国家总结文件 (2000-2021年).
- 提取了关于放射性头部骨折的当前程序术语 (CPT) 代码的数据.
- 将所有金融数据调整为 2021 年的通货膨胀值.
主要成果:
- 从2000年到2021年,整体治疗率下降了34%.
- 放射性头关节整形术 (RHA) 的利用率增加了247%,而骨质合成 (ORIF) 则下降了55%.
- 在所有手术中,医生平均补偿金增加了22%,其中RHA的增长最大.
结论:
- 在医疗保险受益者中,放射性头部骨折的非手术治疗仍然是最常见的.
- 一个显著的趋势显示,在操作案例中,RHA比ORIF的使用越来越多.
- 对所有放射性头部骨折治疗,特别是RHA的医生补偿金已经增加.
相关概念视频
Fractures: Bone Repair
6.1K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
6.1K
Drug Dosing: Geriatric Patients
334
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
334
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
306
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
306
Pharmacodynamics in Geriatric Patients: Effects of Age
294
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
294
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
294
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
294

